Candriam S.C.A. Sarepta Therapeutics, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 59,508 shares of SRPT stock, worth $6.49 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

59,508

Previous 129,000 53.87%

Holding current value

$6.49 Million

Previous $20.4 Million 63.54%

% of portfolio

0.04%

Previous 0.13%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$124.33 - $156.75 $8.64 Million - $10.9 Million	-69,492 Reduced 53.87%	59,508 $7.43 Million
Q2 2024 Aug 05, 2024	SELL	$113.33 - $163.85 $2.49 Million - $3.6 Million	-22,000 Reduced 14.57%	129,000 $20.4 Million
Q1 2024 May 03, 2024	SELL	$93.7 - $141.53 $2.95 Million - $4.45 Million	-31,445 Reduced 17.24%	151,000 $19.5 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $3.15 Million - $5.83 Million	46,736 Added 34.44%	182,445 $17.6 Million
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $3.66 Million - $4.41 Million	35,709 Added 35.71%	135,709 $16.5 Million
Q2 2023 Aug 08, 2023	SELL	$106.4 - $157.19 $2.36 Million - $3.49 Million	-22,194 Reduced 18.16%	100,000 $11.5 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $3.18 Million - $4.22 Million	27,050 Added 28.43%	122,194 $16.8 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $9.6 Million - $12.6 Million	95,144 New	95,144 $12.3 Million
Q2 2021 Jul 20, 2021	SELL	$69.38 - $86.75 $11.4 Million - $14.2 Million	-164,008 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$125.56 - $178.74 $1.36 Million - $1.93 Million	-10,821 Reduced 6.19%	164,008 $28 Million
Q2 2020 Jul 23, 2020	BUY	$93.0 - $171.7 $904,797 - $1.67 Million	9,729 Added 5.89%	174,829 $28 Million
Q4 2019 Jan 21, 2020	SELL	$76.53 - $135.58 $2.1 Million - $3.73 Million	-27,500 Reduced 14.28%	165,100 $21,000
Q1 2019 May 02, 2019	BUY	$106.67 - $151.68 $7.09 Million - $10.1 Million	66,500 Added 52.74%	192,600 $23 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $291,960 - $446,280	3,000 Added 2.44%	126,100 $13.8 Million
Q3 2018 Nov 07, 2018	BUY	$115.31 - $161.51 $7.39 Million - $10.4 Million	64,100 Added 108.64%	123,100 $19.9 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $789,140 - $1.69 Million	11,000 Added 22.92%	59,000 $7.8 Million
Q1 2018 May 09, 2018	BUY	$54.02 - $82.27 $324,120 - $493,620	6,000 Added 14.29%	48,000 $3.56 Million
Q4 2017 Feb 07, 2018	BUY	$47.64 - $56.75 $2 Million - $2.38 Million	42,000	42,000 $2.34 Million

Others Institutions Holding SRPT

# of Institutions

528

Shares Held

84M

Call Options Held

1.99M

Put Options Held

1.36M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.55B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account